Sarepta terminates CSO Krieg

Sarepta Therapeutics Inc. (NASDAQ:SRPT) disclosed in an SEC filing that Arthur Krieg was terminated as SVP and CSO on July 22. Krieg, co-founder and formerly CEO of RaNA Therapeutics Inc. (Cambridge, Mass.), joined Sarepta in January to run the company's drug discovery and early stage research programs. CEO Chris Garabedian declined to comment on Krieg's termination and said the company does not currently have a replacement. Garabedian did say Sarepta hopes that a future CSO "will have desires that align with fully utilizing the technologies available to our company." ...